QQ客服 官方微博 反馈留言

浏览/检索结果: 共8条，第1-8条 帮助 限定条件 内容类型：会议论文     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 On-Treatment ALT Normalization Has No Statistical Significant Impact on Liver Stiffness Regression in Chinese Chronic Hepatitis B Patients with Advanced Fibrosis or Cirrhosis Receiving Tenofovir Disoproxil Fumarate Therapy 会议论文 作者:  Wei, Lai;  Shang, Jia;  Xie, Qing;  Jia, Zhansheng;  Gao, Pujun 收藏  |  浏览/下载：8/0  |  提交时间：2019/12/05 On-Treatment ALT Normalization Has No Statistical Significant Impact on Liver Stiffness Regression in Chinese Chronic Hepatitis B Patients with Advanced Fibrosis or Cirrhosis Receiving Tenofovir Disoproxil Fumarate Therapy 会议论文 作者:  Wei, Lai;  Shang, Jia;  Xie, Qing;  Jia, Zhansheng;  Gao, Pujun 收藏  |  浏览/下载：9/0  |  提交时间：2019/11/19 Refined quantitative assessment of septa to determine the different type of septa in chronic hepatitis B patients. 会议论文 作者:  Wang, Bingqiong;  Sun, Yameng;  Zhou, Jialing;  Wu, Xiao N.;  Kong, Yuanyuan 收藏  |  浏览/下载：4/0  |  提交时间：2019/12/05 leQuantitative assessment of liver fibrosis regression is useful for identifying intra-stage improvements after anti-HBV treatment in chronic hepatitis B patients with paired liver biopsy 会议论文 作者:  Chen, Yongpeng;  You, Hong;  Jia, Jidong;  Zhou, Jialing;  Wang, Lin 收藏  |  浏览/下载：3/0  |  提交时间：2019/12/05 Post-treatment dynamic changes of liver stiffness to predict first 2-year outcomes in HBV compensated cirrhosis 会议论文 作者:  Wu, Shanshan;  Wu, Xiaoning;  Sung, Yameng;  Feng, Bo;  Mao, YiMin 收藏  |  浏览/下载：4/0  |  提交时间：2019/12/13 Baseline Quantitative Hepatitis B Core antibody is the Strongest Predictor for 2-year HBeAg seroconversion in HBeAg Positive CHB Patients Treated with Telbivudine Alone or Combined with Adefovir 会议论文 作者:  Cheng, Jun;  Yu, Yanyan;  Wang, Hao;  Xu, Min;  Shi, Guangfeng 收藏  |  浏览/下载：3/0  |  提交时间：2019/12/05 Baseline Quantitative Hepatitis B Core antibody is the Strongest Predictor for 2-year HBeAg seroconversion in HBeAg Positive CHB Patients Treated with Telbivudine Alone or Combined with Adefovir 会议论文 作者:  Sun, Jian;  Yuan, Quan;  Xie, Qing;  Fan, Rong;  Tan, Deming 收藏  |  浏览/下载：3/0  |  提交时间：2019/12/19 LONG TERM TELBIVUDINE THERAPY WITH EFFECTIVE VIRAL CONTROL RESULTS IN RESOLUTION OF LIVER FIBROSIS AND INFLAMMATION ACHIEVING TREATMENT GOALS IN PATIENTS WITH CHRONIC HEPATITIS B 会议论文 作者:  Hou, Jilin;  Xu, Dao-Zhen;  Shi, Guanfeng;  Goodman, Zachary;  Wan, Mobin 收藏  |  浏览/下载：7/0  |  提交时间：2019/12/19